P-283 Paclitaxel plus valproic acid versus paclitaxel alone as second or third line therapy for advanced gastric cancer: a randomized phase 2 trial

Authors :: T. Ohta
Takashi Fujimura
Jun Kinoshita
T. Takeda
M. Kaji
Kaeko Oyama
S. Ohyama
Yasuo Hirono
H. Nezuka
Sachio Fushida
Tomoya Tsukada
Source :: Annals of Oncology. 27:ii82
Publication Year :: 2016
Publisher :: Elsevier BV, 2016.

Subjects :: Oncology
medicine.medical_specialty
Valproic Acid
business.industry
Third-line therapy
Hematology
Advanced gastric cancer
Abstracts
chemistry.chemical_compound
Text mining
Paclitaxel
chemistry
Internal medicine
medicine
business
medicine.drug

Full Text Access

Tools